Status:
TERMINATED
Polyp Measurement Device
Lead Sponsor:
NYU Langone Health
Conditions:
Colorectal Cancer
Eligibility:
All Genders
50-85 years
Phase:
NA
Brief Summary
Colorectal cancer is the second-leading cause of cancer death in the United States. Colorectal cancer screening is recommended to begin at age 50 years for most men and women at average risk for this ...
Eligibility Criteria
Inclusion
- Individuals age 50-85 years old, who require an outpatient screening or surveillance colonoscopy
- Ability to give consent
Exclusion
- Pregnancy
- Inflammatory bowel disease
Key Trial Info
Start Date :
June 24 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2020
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT03856255
Start Date
June 24 2019
End Date
June 1 2020
Last Update
June 14 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York University School of Medicine
New York, New York, United States, 10016